Rapid Itch Relief With Upadacitinib Vs Dupilumab in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: Results from the Phase 3b 4 Level Up Study. J of Skin 2026, 10 (2), s735. https://doi.org/10.25251/078a3s70.